|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/02/20 GB Sciences Inc. 10-Q 6/30/20 52:4.7M RDG Filings/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 416K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 19K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 19K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 16K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 16K
12: R1 Document And Entity Information HTML 44K
13: R2 Condensed Consolidated Balance Sheets (Current HTML 107K
Period Unaudited)
14: R3 Condensed Consolidated Balance Sheets (Current HTML 30K
Period Unaudited) (Parentheticals)
15: R4 Condensed Consolidated Statements of Operations HTML 100K
(Unaudited)
16: R5 Condensed Consolidated Statements of Cash Flows HTML 148K
(Unaudited)
17: R6 Condensed Consolidated Statements of Stockholders' HTML 72K
Equity (Unaudited)
18: R7 Note 1 - Background and Significant Accounting HTML 107K
Policies
19: R8 Note 2 - Going Concern HTML 22K
20: R9 Note 3 - Inventory HTML 29K
21: R10 Note 4 - Leases HTML 41K
22: R11 Note 5 - Notes Payable and Line of Credit HTML 47K
23: R12 Note 6 - Convertible Notes HTML 49K
24: R13 Note 7 - Capital Transactions HTML 21K
25: R14 Note 8 - Commitments and Contingencies HTML 29K
26: R15 Note 9 - Related Party Transactions HTML 21K
27: R16 Note 10 - Sale of 50% Membership Interest in GB HTML 28K
Sciences Louisiana, LLC
28: R17 Note 11 - Sale of Membership Interests in Nevada HTML 28K
Subsidiaries
29: R18 Note 12 - Subsequent Events HTML 29K
30: R19 Significant Accounting Policies (Policies) HTML 126K
31: R20 Note 1 - Background and Significant Accounting HTML 74K
Policies (Tables)
32: R21 Note 3 - Inventory (Tables) HTML 29K
33: R22 Note 4 - Leases (Tables) HTML 36K
34: R23 Note 5 - Notes Payable and Line of Credit (Tables) HTML 34K
35: R24 Note 1 - Background and Significant Accounting HTML 22K
Policies (Details Textual)
36: R25 Note 1 - Background and Significant Accounting HTML 74K
Policies - Discontinued Operations (Details)
37: R26 Note 2 - Going Concern (Details Textual) HTML 25K
38: R27 Note 3 - Inventory - Schedule of Inventory HTML 27K
(Details)
39: R28 Note 4 - Leases (Details Textual) HTML 41K
40: R29 Note 4 - Leases - Future Minimum Lease Payments HTML 62K
(Details)
41: R30 Note 5 - Notes Payable and Line of Credit (Details HTML 103K
Textual)
42: R31 Note 5 - Notes Payable and Line of Credit - HTML 42K
Schedule of Debt Payable (Details)
43: R32 Note 6 - Convertible Notes (Details Textual) HTML 199K
44: R33 Note 7 - Capital Transactions (Details Textual) HTML 36K
45: R34 Note 8 - Commitments and Contingencies (Details HTML 55K
Textual)
46: R35 Note 9 - Related Party Transactions (Details HTML 31K
Textual)
47: R36 Note 10 - Sale of 50% Membership Interest in GB HTML 68K
Sciences Louisiana, LLC (Details Textual)
48: R37 Note 11 - Sale of Membership Interests in Nevada HTML 48K
Subsidiaries (Details Textual)
49: R38 Note 12 - Subsequent Events (Details Textual) HTML 72K
51: XML IDEA XML File -- Filing Summary XML 90K
50: EXCEL IDEA Workbook of Financial Reports XLSX 59K
6: EX-101.INS XBRL Instance -- gblx-20200630 XML 1.21M
8: EX-101.CAL XBRL Calculations -- gblx-20200630_cal XML 131K
9: EX-101.DEF XBRL Definitions -- gblx-20200630_def XML 1.19M
10: EX-101.LAB XBRL Labels -- gblx-20200630_lab XML 856K
11: EX-101.PRE XBRL Presentations -- gblx-20200630_pre XML 1.17M
7: EX-101.SCH XBRL Schema -- gblx-20200630 XSD 142K
52: ZIP XBRL Zipped Folder -- 0001437749-20-019228-xbrl Zip 135K
| ex_168439.htm |
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, John Poss, certify that:
1.I have reviewed this quarterly report on Form 10-Q of GB Sciences, Inc.;
2.Based on my knowledge, the quarterly report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls.
|
Date: September 2, 2020 |
/s/ John Poss |
|
|
John Poss, Chief Executive Officer (Principal Executive Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/2/20 | |||
| For Period end: | 6/30/20 | NT 10-Q | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/28/20 GB Sciences Inc. 10-K 3/31/20 96:12M RDG Filings/FA 6/27/14 GB Sciences Inc. 10-K 3/31/14 11:1.2M Henrie Gary R/FA 2/12/02 GB Sciences Inc. SB-2 1:166K Elec Delivery Sy… Inc/FA |